FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched BD® Research Cloud, a cloud-based ...
To schedule time for flow analysis, call 977-8877. Leave a message if you are unable to reach us immediately and we will return your call as soon as possible. Users are also welcome to stop by the ...
PARIS & PHILADELPHIA--(BUSINESS WIRE)--METAFORA biosystems, a company that’s leveraging its AI-powered flow cytometry platform to generate improved IVDs and more effective cell therapies, today ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of new NovoExpress software that introduces integrated compliance tools for NovoCyte flow ...
Cytek Biosciences, Inc. has launched the Cytek® Muse® Micro, an enhanced version of its original Guava® Muse® cell analyzer, aimed at making advanced cell analysis more accessible and affordable. The ...
Subjectivity in flow-cytometry data analysis has long been a challenge. Recent advancements in high-speed camera capabilities have led to the integration of morphological features with traditional ...
Zacks Investment Research on MSN
BD and Penn Institute ink collaboration to advance immunotherapy
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with the Institute for ...
What are cell and gene therapies? Cell and gene therapies are utilized to treat diseases and, in some cases, cure diseases by targeting the underlying proteins or genes. Overlaps between these ...
Flow cytometry is not just a technique. It has matured into a scientific field, one that has become virtually indispensable for most areas of biomedical research. Some of its more well-known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback